APPLICATION
NDA019943
TYPE
NDA
ORIGINAL APPROVAL
1995-03-30
LATEST ACTION
2025-09-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
LUPRON DEPOTPrescription
LEUPROLIDE ACETATE 3.75MG · INJECTABLE · INJECTION
Approval history
2002-09-20Manufacturing (CMC) · Supplement 19 · standardAP
2002-05-23Manufacturing (CMC) · Supplement 17 · standardAP
2002-02-21Manufacturing (CMC) · Supplement 16 · standardAP
2001-11-14Labeling · Supplement 15 · standardAP
2001-03-01Labeling · Supplement 14 · standardAP
2001-01-24Manufacturing (CMC) · Supplement 13 · standardAP
2000-05-12Manufacturing (CMC) · Supplement 12 · standardAP
2000-05-11Manufacturing (CMC) · Supplement 11 · standardAP
1998-06-30Manufacturing (CMC) · Supplement 9 · standardAP
1997-06-27Manufacturing (CMC) · Supplement 7 · standardAP
1996-09-12Labeling · Supplement 6 · standardAP
1995-12-12Labeling · Supplement 2 · standardAP
1995-09-22Manufacturing (CMC) · Supplement 1 · standardAP
1995-08-11Manufacturing (CMC) · Supplement 4 · standardAP
1995-03-30Type 5 - New Formulation or New Manufacturer · Original · standard — Other Important Information from FDA ↗AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.